ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Will Immunotherapy Be a PANACEA for Breast Cancer? – Medscape

MedscapeWill Immunotherapy Be a PANACEA for Breast Cancer?MedscapeKathy D. Miller, MD: Hi. I am Dr Kathy Miller, professor of medicine at the Indiana University School of Medicine in Indianapolis. Welcome to Medscape Oncology Insights, coming to you fr… Continue reading

2018-01-02 Michael Zand NEWS

Cancer Immunotherapy Developer Armo BioSciences Files for Up-to-$86.25M IPO – Genetic Engineering & Biotechnology News

San Francisco Business TimesCancer Immunotherapy Developer Armo BioSciences Files for Up-to-$86.25M IPOGenetic Engineering & Biotechnology NewsArmo BioSciences, a late-stage developer of cancer immunotherapies, will seek to raise up to $86.25 million i… Continue reading

2018-01-02 Michael Zand NEWS

Indian scientists have developed a mechanism to rejuvenate aged stem cells – Firstpost

FirstpostIndian scientists have developed a mechanism to rejuvenate aged stem cellsFirstpostThe mechanism developed by researchers at the National Centre for Cell Science (NCCS), Pune involves rejuvenating aged hematopoietic stem cells in a short-term … Continue reading

2018-01-02 Michael Zand NEWS

Sorrento Therapeutics (SRNE) Says it Will Present Potential ‘Game-Changer’ Non-Viral CAR-T Technology for … – StreetInsider.com

Continue reading

2018-01-02 Michael Zand NEWS

Sorrento Therapeutics to Present Potential “Game-Changer” Non-Viral CAR-T Technology for Autologous and … – GlobeNewswire (press release)

Sorrento Therapeutics to Present Potential “Game-Changer” Non-Viral CAR-T Technology for Autologous and …GlobeNewswire (press release)This innovative non-viral CAR-T technology may offer several potential benefits over existing virus-based technology… Continue reading

2018-01-02 Michael Zand NEWS

Compugen Announces Presentations at Three Upcoming Cancer Immunotherapy Conferences – PR Newswire (press release)

Compugen Announces Presentations at Three Upcoming Cancer Immunotherapy ConferencesPR Newswire (press release)Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today … Continue reading

2018-01-02 Michael Zand NEWS

NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development – GlobeNewswire (press release)

NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical DevelopmentGlobeNewswire (press release)GAITHERSBURG, Md., Jan. 02, 2018 (GLOBE NEWSWIRE) — NexImmune, an emerging leader in the field of antigen-directed immunoth… Continue reading

2018-01-02 Michael Zand NEWS

In a milestone year, gene therapy finds a place in medicine | Health … – The Philadelphia Tribune

The Philadelphia TribuneIn a milestone year, gene therapy finds a place in medicine | Health …The Philadelphia TribuneAfter decades of hope and high promise, this was the year scientists really showed they could doctor DNA to successfully treat disea… Continue reading

2018-01-02 Michael Zand NEWS
  • 1
  • …
  • 724
  • 725
  • 726
  • 727
  • 728
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Sorrento Therapeutics (SRNE) Says it Will Present Potential ‘Game-Changer’ Non-Viral CAR–T Technology for …
StreetInsider.com
This innovative non-viral CAR-T technology may offer several potential benefits over existing virus-based technology using CAR gene-encoding lentivirus, retrovirus or adeno-associated virus (AAV) to introduce CAR constructs into healthy donor …

and more »